CYTOTOXIC ACTIVITY OF TAXOL IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS IS PARTLY MEDIATED BY CREMOPHOR EL

被引：48

作者：

NYGREN, P

CSOKA, K

JONSSON, B

FRIDBORG, H

BERGH, J

HAGBERG, H

GLIMELIUS, B

BRODIN, O

THOLANDER, B

KREUGER, A

LONNERHOLM, G

JAKOBSSON, A

OLSEN, L

KRISTENSEN, J

LARSSON, R

机构：

[1] UNIV UPPSALA HOSP, DIV CLIN PHARMACOL, S-75185 UPPSALA, SWEDEN

[2] UNIV UPPSALA HOSP, DEPT GYNECOL ONCOL, S-75185 UPPSALA, SWEDEN

[3] UNIV UPPSALA HOSP, DEPT PEDIAT, S-75185 UPPSALA, SWEDEN

[4] UNIV UPPSALA HOSP, DEPT PEDIAT SURG, S-75185 UPPSALA, SWEDEN

[5] UNIV UPPSALA HOSP, DEPT INTERNAL MED, S-75185 UPPSALA, SWEDEN

来源：

BRITISH JOURNAL OF CANCER | 1995年 / 71卷 / 03期

关键词：

TAXOL; CREMOPHOR EL; PRIMARY CULTURE; TUMOR CELL;

D O I：

10.1038/bjc.1995.97

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In patient tumour samples the activity in vitro of Taxol corresponded fairly well to the known clinical activity and Taxol showed low cross-resistance to standard cytotoxic drugs. However, the Taxol solvent Cremophor EL-ethanol was considerably active alone, whereas paclitaxel formulated in ethanol was less active. Taxol thus seems to contain two components active against patient tumour cells in vitro.

引用

页码：478 / 481

页数：4

共 27 条

[1] ALTERED PLASMA-MEMBRANE ULTRASTRUCTURE IN MULTIDRUG-RESISTANT CELLS
ARSENAULT, AL
LING, V
KARTNER, N
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 938 (02) : 315 - 321
[2] BUDAVARI S, 1989, MERCK INDEX, P290
[3] ONCOLYTIC EFFECTS OF FATTY-ACIDS IN MICE AND RATS
BURTON, AF
[J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (04) : S1082 - S1086
[4] CHANG A, 1992, P AM SOC CLIN ONCOL, V11, pA981
[5] COLTON T, 1974, STATISTICS MED
[6] PHASE-II TRIAL OF TAXOL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
EINZIG, AI
GOROWSKI, E
SASLOFF, J
WIERNIK, PH
[J]. CANCER INVESTIGATION, 1991, 9 (02) : 133 - 136
[7] PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA
EINZIG, AI
WIERNIK, PH
SASLOFF, J
RUNOWICZ, CD
GOLDBERG, GL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) : 1748 - 1753
[8] FJALLSKOG ML, 1994, EUR J CANCER, V30A, P687
[9] PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER
HOLMES, FA
WALTERS, RS
THERIAULT, RL
FORMAN, AD
NEWTON, LK
RABER, MN
BUZDAR, AU
FRYE, DK
HORTOBAGYI, GN
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) : 1797 - 1805
[10] SDZ PSC-833 - A NOVEL POTENT INVITRO CHEMOSENSITIZER IN MULTIPLE-MYELOMA
JONSSON, B
NILSSON, K
NYGREN, P
LARSSON, R
[J]. ANTI-CANCER DRUGS, 1992, 3 (06) : 641 - 646

← 1 2 3 →